| Symbol | Sector | Firm | Action | Grade | Target | Mkt Cap ▼ | Base | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRM | Technology | Citigroup | Maintains | Neutral → Neutral | — | $171.5B | $209.91 | +1.4% | +2.6% | +1.6% | +2.1% | -4.7% | +0.1% |
| MRVL | Technology | Citigroup | Maintains | Buy → Buy | — | $153.3B | $49.47 | +18.6% | +32.4% | -3.2% | -7.7% | +4.5% | -1.5% |
| NTES | Technology | Citigroup | Maintains | Buy → Buy | — | $73.9B | $85.73 | +2.0% | +4.4% | -5.1% | +0.1% | +0.8% | +1.0% |
| SNOW | Technology | Citigroup | Maintains | Buy → Buy | — | $57.2B | $147.91 | -0.7% | +1.4% | +5.8% | +4.2% | +1.2% | +4.7% |
| WDAY | Technology | Citigroup | Maintains | Neutral → Neutral | — | $34.1B | $196.41 | +9.4% | +10.0% | -3.2% | +1.4% | +1.6% | -0.8% |
| ULTA | Consumer Cyclical | Citigroup | Maintains | Neutral → Neutral | — | $21.7B | $485.12 | -10.1% | -13.4% | -3.2% | +0.8% | -1.5% | +4.6% |
| DLTR | Consumer Defensive | Citigroup | Maintains | Buy → Buy | — | $18.7B | $136.66 | -0.1% | +4.2% | -2.8% | -2.6% | -3.9% | +3.1% |
| GH | Healthcare | CitigroupC | Upgrade | Neutral → Buy | — | $12.3B | $27.87 | +7.6% | +0.8% | +2.1% | +2.3% | +7.1% | +3.2% |
| EXP | Basic Materials | Citigroup | Maintains | Buy → Buy | — | $6.7B | $166.56 | +0.1% | -0.2% | -0.9% | -1.0% | +0.1% | +3.7% |
| RCUS | Healthcare | Citigroup | Maintains | Buy → Buy | — | $2.4B | $17.50 | +18.6% | +25.9% | -8.0% | +1.4% | -1.2% | +3.5% |
| RH | Consumer Cyclical | Citigroup | Maintains | Buy → Buy | — | $2.4B | $254.63 | -4.3% | -3.1% | +2.0% | -2.7% | -0.1% | +3.1% |
| CPRI | Consumer Cyclical | Citigroup | Maintains | Buy → Buy | — | $2.0B | $39.21 | -0.3% | +1.9% | -1.0% | -11.3% | -1.9% | +4.9% |